The question at hand: what is the relative transmission potential of a vaccinated person who becomes infected with delta? This 👇new report from Singapore is much more informative on this question than the CT data released so far from Ptown and Wisconsin. medrxiv.org/content/10.110…
First, importantly, reducing transmission potential of a person who becomes infected is only one component on the transmission reduction effect of the vaccines. The other: reducing the likelihood of becoming infected in the first place. We discuss here👇 academic.oup.com/ofid/advance-a…
We still await definitive evidence from systematic sampling on the ? of overall infection risk reduction with vaccination, but w strong protection vs symptomatic disease, expect that there will still be substantial protection (50+%) vs overall infection nejm.org/doi/full/10.10…
Back to the Singapore data - these investigators report features of 218 people hospitalized with delta (all covid is hospitalized in Singapore). 84 had received an mrna vaccine (71 fully vaccinated). Unlike ptown/wisconsin data, can see that vaxed significantly older.
Like ptown/wisconsin data, the CT values at diagnosis are similar (~19). This is 1 piece of data suggesting viral loads *might* be similar at diagnosis. However, there are a number of impt factors that continue to suggest substantially reduced transmission potential among vaxd:
1st, the pattern of CT measurements suggests more rapid viral decay (left). For alpha, increased transmission risk vs ancestral virus was mediated by longer (not higher) peak viral load (right, dash.harvard.edu/handle/1/37366…). We don't know this yet for delta, some think an earlier peak
2nd, the vaccinated ppl infected with delta had greatly reduced symptoms (left=unvax), including a much greater likelihood of being asymptomatic. This will have substantial effect on transmission potential. Some refs: pubmed.ncbi.nlm.nih.gov/33484843/ thelancet.com/journals/lance…
3rd, antibody testing showed high levels of neutralization activity in the vaccinated ppl who were infected. This is the most hypothetical mechanism of reduced transmission potential, but if this neutralization is occurring in the upper airway it is very plausible.
So, transmission reduction is much more complicated than the CT value at diagnosis. That why things like this 👇 are so misleading. If interested, discuss many more details here with @EricMeyerowitz and @mugecevik : academic.oup.com/ofid/advance-a…
Interesting poll. Selection/response bias aside, majority picked a low probability, but 40% still thought there was 10+% prob that vaccines will not substantially prevent transmission. This is why I have become convinced this concern is highly unlikely (borderline implausible) 🧵
1. Data from screening PCR at the time of the 2nd moderna mrna vaccine, showing reductions in asymptomatic PCR positivity. This is before the 2nd dose and if anything will underestimate effect. Will have additional confirmation from unblinding pcr and ab
Thankful to Singapore for surveillance systems that allow for the detailed studies required to truly assess the relative transmission risk of asymptomatic vs symptomatic cov-2 👇, which they find to be much higher in those who develop symptoms /1
Yesterday @EricMeyerowitz and I presented insights from new COVID19 papers published over the last month at the HOPE conference. Posting slides and video if interested
Political appointees move to silence @CDCMMWR reports, the weekly lifeline from a barely functioning institution and the cornerstone of public health reporting in the US
Selection of reports that have been essential to understanding the US epidemic 👇🏻
This is the key observation that somehow has not really made it outside of hospital circles. Still waiting for the first detailed report from a large health system of in-hospital transmissions in the universal masking era. Per hospital epis I’ve spoken with close to 0
This Lancet report gets highly referenced suggesting healthcare workers higher risk but 1) much of it pre-universal masking 2) don’t report whether community acquired (much of it is per other publications from healthcare) 3) no contact tracing
This paper of 226 patient contacts of healthcare workers w CoV2 (both pre and post universal masking) is probably the best 1 on the subject — they found one possible transmission, during a 30 minute encounter w both patient and healthcare worker unmasked
Really nice to see this WHO analysis in JAMA (along w 3 RCTs) put to bed the importance of corticosteroids in ventilated patients w COVID-19. A lot of good stuff here.
So what to do w steroids in those requiring supp O2 only? /1
RECOVERY results suggest a mortality benefit in this population (supp O2 only), and I have seen basically every patient in this category receive dex, appropriately... but there are enough odd features of this single open-label trial that make me wonder. /2
Much of this nuance is explained well in this thread by @FranciscoMarty_
The main thing that nags me personally is how ridiculously high the mortality was in RECOVERY - 26.2% among those requiring O2 and receiving usual care /3